BlackRock Advisors’s Allergan plc AGN.PRA Stock Holding History

BlackRock Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$87.8M	Sell	115,182 -7,808	-6%	-$5.9M	0.09%	224
2016 Q3	$101M	Sell	122,990 -10,329	-8%	-$8.93M	0.1%	213
2016 Q2	$111M	Sell	133,319 -40,153	-23%	-$33.5M	0.11%	192
2016 Q1	$159M	Sell	173,472 -7,660	-4%	-$7.32M	0.17%	138
2015 Q4	$186M	Sell	181,132 -5,808	-3%	-$5.83M	0.2%	124
2015 Q3	$176M	Buy	+186,940	New	+$195M	0.19%	128

Other funds holding AGN.PRA

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Advisors's AGN.PRA Position: Q4 2016 in Review

BlackRock Advisors reduced its Allergan plc (AGN.PRA) stake by 6.3% in Q4 2016, selling an estimated $5.9M and leaving 115,182 shares worth $87.8M. The position accounts for 0.09% of the portfolio, ranked #224.

BlackRock Advisors first reported a position in AGN.PRA in Q3 2015 and has held it in 6 quarters since. The position peaked at $186M in Q4 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.

BlackRock Advisors held 115,182 shares of Allergan plc worth $87.8M as of Q4 2016.
BlackRock Advisors sold 7,808 Allergan plc shares in Q4 2016, an estimated $5.9M.
Allergan plc made up 0.09% of BlackRock Advisors's portfolio in Q4 2016, its #224 holding.
BlackRock Advisors first reported a position in Allergan plc in Q3 2015 and has held it in 6 quarters since.
BlackRock Advisors's Allergan plc position peaked at $186M in Q4 2015.
108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.